Abstract:BACKGROUND: In this study, we found that maspin affects the development of drug resistance in lung adenocarcinoma. Therefore, it is important to clarify the role and mechanism of mammary serine protease inhibitor (maspin) in the regulation of adenocarcinoma drug resistance in order to improve individualized clinical treatment protocols and drug resistance interventions.METHODS: Immunohistochemical was used to detect maspin expression in tissue chip samples of 75 patients diagnosed with lung adenocarcinoma and treated with a taxus chemotherapy regimen, and the correlation between maspin, clinicopathological factors, and prognosis was analyzed. The expression of maspin in a human lung adenocarcinoma docetaxel-resistant cell line, SPC-A1/DTX, and its parent cells were detected by reverse transcription polymerase chain reaction (RT-PCR) and western blot assay. MTT and flow cytometry were used to detect the effects of knockdown or overexpression of maspin on chemotherapy sensitivity and apoptosis in lung cancer cells. Tumor cells were also analyzed in vivo to determine their tumorigenic ability and susceptibility to docetaxel.RESULTS: Maspin is poorly expressed in lung adenocarcinoma tissue chips that have received a taxus chemotherapy regimen, and is also closely related to poor grading, late stage, lymph node metastasis, and poor prognosis. Maspin has a low expression in drug-resistant cells, and the expression level of maspin decreases significantly with increases in docetaxel concentration and over time. In drug-resistant cells, knockdown of maspin can significantly affect the sensitivity of drug-resistant cells to docetaxel. In the chemotherapy-sensitive strain SPC-A1, maspin was mainly located in the cell nucleus, while in the chemotherapy-resistant strain SPC-A1/DTX, maspin was mainly located in the cytoplasm. An in vivo nude mouse xenograft model showed that an overexpression of maspin significantly increased the inhibitory effect of docetaxel on tumor-bearing tissues and the apoptosis rate, and markedly reduced tumor weight, volume, and the Ki-67-positive rate.CONCLUSIONS: In vitro and in vivo experiments show that overexpression of maspin can increase the sensitivity of lung cancer drug-resistant cells to chemotherapy drugs, suggesting that the expression level of maspin could be used as a molecular marker to predict lung cancer drug resistance to docetaxel.

The Roles of MASPIN Expression and Subcellular Localization in Non-Small Cell Lung Cancer

Clinicopathological and Prognostic Significance of Maspin Expression in Resected Non-Small Cell Lung Cancer: A Meta-Analysis

Maspin Expression and Its Clinical Significance in Non-Small Cell Lung Cancer

Expression of Maspin in Non-small Cell Lung Cancer and Its Relationship to Vasculogenic Mimicry

A meta‐ and bioinformatics analysis of maspin expression levels influencing the prognosis of patients with breast cancer

Decreased Maspin Combined with Elevated Vascular Endothelial Growth Factor C is Associated with Poor Prognosis in Non-Small Cell Lung Cancer

[Mammary Serine Proteinase Inhibitor Subcellular Expression in Oral Squamous Cell Carcinoma and Its Clinical Significance].

[Expression of Mammary Serine Proteinase Inhibitor in Oral Squamous Cell Carcinoma and Its Clinical Significance].

Expression of MASPIN and its role in epithelian ovarian cancer

Opposing Functions of Maspin Are Regulated by Its Subcellular Localization in Lung Squamous Cell Carcinoma Cells

The role of MASPIN in ovarian carcinoma

Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis

Mammary serine protease inhibitor inhibits epithelial growth factor-induced epithelial-mesenchymal transition of esophageal carcinoma cells.

Clinicopathological Significance of Maspin Expression in Breast Cancer.

Elevated Maspin Expression is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC).

PI3K-AKT, JAK2-STAT3 pathways and cell-cell contact regulate maspin subcellular localization

[Clinical Significance of Multidrug Resistance-Associated Protein(mrp) Gene Expression in Non-Small Cell Lung Cancer].

MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

The overexpression of maspin increases the sensitivity of lung adenocarcinoma drug-resistant cells to docetaxel in vitro and in vivo

Maspin Enhances Cisplatin Chemosensitivity in Bladder Cancer T24 and 5637 Cells and Correlates with Prognosis of Muscle-Invasive Bladder Cancer Patients Receiving Cisplatin Based Neoadjuvant Chemotherapy

SERPINB5 is a Prognostic Biomarker and Promotes Proliferation, Metastasis and Epithelial‐mesenchymal Transition (EMT) in Lung Adenocarcinoma